Botulinum a toxin for cranial-cervicaldystonia: A double-blind, placebo-controlled study

Neurology

Volumn 37, Issue 4, 1987, Pages 616-623

  Jankovic, Joseph ^a   Orman, Janet ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADVERSE DRUG REACTION; BLEPHAROSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG THERAPY; DYSARTHRIA; DYSPHAGIA; DYSTONIA; ESOPHAGUS; HEADACHE; HUMAN; MUSCLE; PHARYNX; PRIORITY JOURNAL; SORE THROAT; SPASTIC DYSPHONIA; THERAPY; VISUAL SYSTEM;

ADOLESCENT; ADULT; BASAL GANGLIA DISEASES; BLEPHAROSPASM; BOTULINUM TOXINS; DOUBLE-BLIND METHOD; DYSTONIA; FEMALE; HUMAN; MALE; MEIGE SYNDROME; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; VOICE DISORDERS;

EID: 0023142826     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.37.4.616     Document Type: Article

References (26)

1. Fahn S. The varied clinical expressions of dystonia. In: Jankovic J, ed. Neurologic clinics, vol 2. Philadelphia: WB Saunders Co, 1984:541-554.
2. Jankovic J. Clinical features, differential diagnosis and pathogenesis of blepharospasm and cranial-cervical dystonia. In: Bosniak SL, ed. Blepharospasm. Adv Opth Plastic Reconstructive Surg, vol 4. New York: Pergamon Press, 1985:67-82.
3. Jankovic J. Blepharospasm with basal ganglia lesions. Arch Neurol 1986;43:866-868.
4. Jankovic J, Nutt JG. The genetics of blepharospasm and orofacial-cervical dystonia (Meige syndrome). Abstract. Neurology 1985;35(suppl 1):271.
5. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacologic findings in 100 patients. Ann Neurol 1983;13:402-411.
6. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981;79:734-770.
7. Frueh BR, Felt DP, Wojno TH, Musch DC. Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch Ophthalmol 1984;102:1464-1468.
8. Scott AB, Kennedy RA, Stubbs MA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-350.
9. Elston JS, Russell RWR. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J 1985;290:1857-1859.
10. Tsoy EA, Buckley EG, Dutton JJ. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol 1985;99:176-179.
11. Shorr N, Seiff SR, Kopelman J. The use of botulinum toxin in blepharospasm. Am J Ophthalmol 1985;99:542-546.
12. Lingua RW. Sequelae of botulinum toxin injection. Am J Ophthalmol 1985;100:305-307.
13. Savino PJ, Sergott RC, Bosley TM, Schatz NJ. Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol 1985;103:1305-1306.
14. Mauriello JA. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology 1985;35:1499-500.
15. Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Caine DB. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985;12:314-316.
16. Perman KI, Baylis HI, Rosenblum AL, Kirschen DG. The use of botulinum toxin in the medical management of benign essential blepharospasm. Ophthalmology 1986;93:1-3.
17. Dutton JJ, Buckley EG. Botulinum toxin in the management of blepharospasm. Arch Neurol 1986;43:380-382.
18. Brin MF, Fahn S, Moskowitz CB, et al. Injections of botulinum toxin for the treatment of focal dystonia. Abstract. Neurology 1986;36(suppl 1):120.
19. Fahn S. Rating scales for blepharospasm. In: Bosniak SL, ed. Blepharospasm. Adv Ophth Plastic Reconstructive Surg, vol 4. New York: Pergamon Press Inc, 1985:97-101.
20. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: double-blind crossover study. Ann Neurol 1982;11:41-47.
21. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonia. Neurology 1985;35:73-77.
22. Friedman A, Fahn S. Spontaneous remissions in spasmodic torticollis. Neurology 1986;36:398-400.
23. Sellin LC. The action of botulinum toxin at the neuromuscular junction. Med Biol 1981;59:11-20.
24. Dolly JO, Black J, Williams RS, Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 1984;307:457-460.
25. Battista AF. Percutaneous thermolytic fractional destruction of branches of the facial nerve for the relief of blepharospasm. In: Bosniak SL, ed. Blepharospasm. Adv Ophth Plastic Reconstructive Surg, vol 4. New York: Pergamon Press Inc, 1985:369-377.
26. Callahan A. Neurectomy of the facial nerve plexus and partial removal of orbicularis muscle for blepharospasm. In: Bosniak SL, ed. Blepharospasm. Adv Ophth Plastic Reconstructive Surg, vol 4. New York: Pergamon Press Inc, 1985:379-384.